Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tuberculosis | 23 | 2020 | 2895 | 3.65 | Why? |
| Tuberculosis, Pulmonary | 6 | 2020 | 1171 | 1.68 | Why? |
| Antitubercular Agents | 5 | 2019 | 775 | 1.40 | Why? |
| Tuberculosis, Multidrug-Resistant | 4 | 2019 | 433 | 1.04 | Why? |
| Faith-Based Organizations | 1 | 2020 | 44 | 0.83 | Why? |
| Tuberculosis, Lymph Node | 1 | 2019 | 27 | 0.82 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.72 | Why? |
| Latent Tuberculosis | 2 | 2019 | 324 | 0.71 | Why? |
| Infectious Disease Medicine | 2 | 2018 | 311 | 0.67 | Why? |
| Extensively Drug-Resistant Tuberculosis | 1 | 2017 | 87 | 0.63 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.56 | Why? |
| Global Health | 10 | 2020 | 13911 | 0.49 | Why? |
| Social Stigma | 1 | 2020 | 1049 | 0.44 | Why? |
| Public Policy | 2 | 2020 | 1894 | 0.42 | Why? |
| Cost of Illness | 2 | 2018 | 1903 | 0.42 | Why? |
| Refugees | 1 | 2019 | 809 | 0.39 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.38 | Why? |
| Politics | 2 | 2020 | 1824 | 0.35 | Why? |
| World Health Organization | 7 | 2020 | 4213 | 0.33 | Why? |
| Health Promotion | 1 | 2019 | 2020 | 0.30 | Why? |
| Child Health Services | 1 | 2012 | 520 | 0.29 | Why? |
| Transients and Migrants | 1 | 2017 | 1468 | 0.28 | Why? |
| International Cooperation | 1 | 2017 | 3436 | 0.26 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.25 | Why? |
| Poverty | 3 | 2020 | 2302 | 0.25 | Why? |
| Maternal Health Services | 1 | 2012 | 808 | 0.25 | Why? |
| Substance-Related Disorders | 1 | 2017 | 2038 | 0.24 | Why? |
| Tuberculin Test | 2 | 2019 | 141 | 0.23 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.22 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.21 | Why? |
| Central America | 1 | 2020 | 86 | 0.21 | Why? |
| Africa, Eastern | 1 | 2019 | 90 | 0.20 | Why? |
| Skin Diseases, Infectious | 1 | 2020 | 77 | 0.20 | Why? |
| Asia, Western | 1 | 2019 | 271 | 0.20 | Why? |
| Epidemics | 3 | 2020 | 6407 | 0.19 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.19 | Why? |
| Caribbean Region | 1 | 2020 | 349 | 0.19 | Why? |
| Anniversaries and Special Events | 1 | 2020 | 127 | 0.19 | Why? |
| Africa, Western | 1 | 2019 | 363 | 0.18 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.18 | Why? |
| Africa, Northern | 1 | 2019 | 539 | 0.18 | Why? |
| Goals | 2 | 2018 | 335 | 0.17 | Why? |
| Interferon-gamma Release Tests | 1 | 2019 | 253 | 0.17 | Why? |
| Patient Advocacy | 1 | 2019 | 173 | 0.17 | Why? |
| Social Discrimination | 1 | 2020 | 269 | 0.16 | Why? |
| Humans | 34 | 2021 | 930598 | 0.16 | Why? |
| Chile | 1 | 2020 | 1095 | 0.15 | Why? |
| Incidence | 7 | 2018 | 25622 | 0.15 | Why? |
| HIV Seropositivity | 1 | 2018 | 320 | 0.15 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.14 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2012 | 5164 | 0.14 | Why? |
| Latin America | 1 | 2020 | 1721 | 0.14 | Why? |
| Health Care Reform | 1 | 2020 | 409 | 0.14 | Why? |
| HIV Infections | 3 | 2020 | 11620 | 0.14 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.13 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.13 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.12 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.12 | Why? |
| One Health | 1 | 2018 | 390 | 0.12 | Why? |
| Mexico | 1 | 2020 | 2787 | 0.11 | Why? |
| Africa | 1 | 2020 | 2986 | 0.11 | Why? |
| Disease Eradication | 1 | 2017 | 581 | 0.11 | Why? |
| Asia | 1 | 2018 | 2399 | 0.11 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.10 | Why? |
| Pulmonary Medicine | 1 | 2017 | 706 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Europe | 2 | 2018 | 12702 | 0.10 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Models, Theoretical | 2 | 2019 | 6659 | 0.10 | Why? |
| Health Priorities | 1 | 2017 | 959 | 0.09 | Why? |
| Italy | 4 | 2020 | 38444 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Communicable Disease Control | 4 | 2018 | 29620 | 0.09 | Why? |
| South Africa | 1 | 2018 | 3326 | 0.09 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Infant, Newborn | 3 | 2019 | 23105 | 0.08 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.08 | Why? |
| Pregnancy Complications, Infectious | 1 | 2012 | 11559 | 0.08 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.07 | Why? |
| Research | 1 | 2018 | 2115 | 0.07 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.06 | Why? |
| Developing Countries | 2 | 2018 | 4283 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| India | 1 | 2018 | 11875 | 0.05 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.05 | Why? |
| Male | 7 | 2021 | 367725 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Infant | 2 | 2019 | 30274 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Female | 6 | 2021 | 380317 | 0.05 | Why? |
| Societies, Medical | 1 | 2014 | 6907 | 0.04 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.04 | Why? |
| Child | 2 | 2019 | 70012 | 0.04 | Why? |
| Preventive Health Services | 1 | 2002 | 501 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Adult | 3 | 2020 | 244371 | 0.04 | Why? |
| Health Services | 1 | 2002 | 765 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.03 | Why? |
| Health Policy | 1 | 2014 | 6242 | 0.03 | Why? |
| Health Expenditures | 1 | 2002 | 904 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.03 | Why? |
| Pregnancy | 1 | 2012 | 23879 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Telemedicine | 1 | 2017 | 25032 | 0.02 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.01 | Why? |
| Budgets | 1 | 2002 | 155 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Contact Tracing | 1 | 2017 | 8448 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Financing, Government | 1 | 2002 | 434 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2002 | 15909 | 0.00 | Why? |